Ozempic Won't Solve America's Obesity Problem
TL;DR
America's obesity crisis stems from a structurally toxic food environment engineered by 1970s shareholder capitalism and agricultural subsidies, making pharmaceutical interventions like Ozempic insufficient without systemic reform to realign incentives toward real food and preventive health.
🏭 The Structural Health Crisis 3 insights
Modern environment structurally inhibits health outcomes
The default American lifestyle systematically produces sickness because the physical and food environment has been engineered for corporate profit rather than human wellbeing.
Seventies marked the toxicity turning point
Shareholder pressure in the 1970s drove food companies to replace real ingredients with processed alternatives like high fructose corn syrup to optimize earnings per share.
Crop subsidies artificially cheapen toxic ingredients
Federal subsidies have poured nearly $100 billion into corn and soy, making inflammatory oils and sweeteners artificially inexpensive and comprising 20% of caloric intake.
💊 Limitations of Pharmaceutical Solutions 2 insights
Ozempic cannot fix food quality issues
GLP-1 drugs suppress appetite but eating less ultraprocessed food leads to dangerous protein and micronutrient deficiencies without addressing dietary composition.
Pharmaceuticals offer no systemic panacea
History shows single pharmaceutical interventions cannot solve complex environmental and cultural crises requiring structural food system reform.
🔄 Pathways to Systemic Reform 3 insights
Reform subsidies to fix food prices
Eliminating subsidies for corn, soy, and wheat would remove the artificial price advantage driving the dominance of ultraprocessed foods.
Redefine lifestyle as healthcare intervention
Tax-advantaged HSA and FSA dollars should cover healthy food, exercise, and supplements when prescribed as prevention for chronic conditions.
Shift payment to prevention not treatment
The healthcare system pays millions for acute heart attacks but nothing for the diet and exercise interventions that prevent them.
Bottom Line
Restructure agricultural subsidies and healthcare reimbursement to make preventive lifestyle interventions affordable and profitable rather than relying on pharmaceutical appetite suppression to manage a toxic food environment.
More from a16z Podcast
View all
Jake Paul on Going From YouTube to Boxing to Investing | a16z ft. Anti Fund
Jake Paul and Anti Fund co-founder Geoffrey Woo announce their oversubscribed $100 million growth fund backed by tier-one LPs like Andreessen Horowitz, while explaining how Paul's resilience and analytical operator mindset translate from entertainment to backing frontier tech companies.
The Media Game Has Changed
The media landscape has shifted from defense-oriented legacy outlets demanding plastic, controversy-free performances to an offense-driven ecosystem where authenticity and founder-led personal brands dominate; success now requires treating public conversations like private ones and building direct channels rather than relying on traditional press.
Why AI Feels Like the Internet in 1997 | Benedict Evans on a16z
Benedict Evans compares today's AI landscape to the internet in 1997, arguing that agentic coding has emerged as the first true product-market fit use case while the industry grapples with severe infrastructure scarcity and an uncertain future where foundation models risk becoming commoditized infrastructure rather than value-capturing platforms.
The Rule for Picking AI Winners | The a16z Show
Frontier AI model companies are achieving hyperscaler-scale revenue growth with less than 5% economic diffusion, creating extraordinary value creation potential, yet rapid technological shifts and uncertain market structures make predicting ultimate winners increasingly difficult compared to prior tech cycles.